We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Diagnosis and Treatment of Cutaneous Anthrax

Jeffrey R. Suchard, MD
JAMA. 2002;288(1):43-44. doi:10.1001/jama.288.1.42.
Text Size: A A A
Published online


To the Editor: Dr Freedman and colleagues1 detailed the clinical course of a 7-month-old infant with cutaneous anthrax. However, I find it disturbing that the working diagnosis, which remained preeminent until hospital day 12, was cutaneous and systemic loxoscelism (ie, recluse spider envenomation). Physicians and patients often ascribe otherwise unexplained skin lesions to Loxosceles reclusa or other spider envenomations with little if any supporting evidence.25 Brown recluse spider bites essentially never occur outside this species' natural geographic range in the south central United States, where they are generally not regarded as a medical calamity,3 as typical of nonendemic regions. It is exceedingly unlikely that someone in the Manhattan area could be envenomated by a brown recluse spider. Without observing either the bite or a spider, the chance that this child (or anyone in a nonendemic area) had cutaneous or systemic loxoscelism was essentially nil, even if the clinical features appeared consistent. Furthermore, assigning the diagnosis of loxoscelism served no useful purpose, because supportive care alone is the mainstay of treatment for brown recluse spider envenomation.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.